Concepedia

Kazutaka Miyadera

KM

Statistics

Publications

25

Citations

2.1K

H-Index

20

Active since

1995

Affiliations

Taiho Pharmaceutical (Japan)(Current)

Kagoshima University

Japan Society of Chemotherapy

Japanese Foundation For Cancer Research

National Cancer Center Hospital East

Kazutaka Miyadera is an author at Taiho Pharmaceutical (Japan) specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1995–2019

25

Publications

25

Clinicopathologic and Prognostic Significance of an Angiogenic Factor, Thymidine Phosphorylase, in Human Colorectal Carcinoma

Y. Takebayashi, Shin‐ichi Akiyama, Suminori Akiba et al. · JNCI Journal of the National Cancer Institute · 1996 · 366 citations

, , +14

The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.

Shigeto Matsushita, Takao Nitanda, Tatsuhiko Furukawa et al. · PubMed · 1999 · 209 citations

, , +12

Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase.

Kazutaka Miyadera, Tomoyuki Sumizawa, Hiroki Yoshida et al. · PubMed · 1995 · 183 citations

, , +6

The activity and expression of thymidine phosphorylase in human solid tumours

Yuji Takebayashi, Kazutaka Yamada, Kazutaka Miyadera et al. · European Journal of Cancer · 1996 · 183 citations

, , +8

UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.

Kazuya Yonekura, Y Basaki, L Chikahisa et al. · PubMed · 1999 · 116 citations

, , +15

1–5 of 25